Humankind Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.42M | Buy |
4,385
+605
| +16% | +$472K | 0.83% | 18 |
|
|
2025
Q1 | $3.12M | Sell |
3,780
-588
| -13% | -$486K | 0.81% | 18 |
|
|
2024
Q4 | $3.37M | Buy |
4,368
+985
| +29% | +$760K | 0.85% | 18 |
|
|
2024
Q3 | $3M | Sell |
3,383
-464
| -12% | -$411K | 1.08% | 13 |
|
|
2024
Q2 | $3.48M | Sell |
3,847
-68
| -2% | -$61.6K | 0.92% | 17 |
|
|
2024
Q1 | $3.05M | Sell |
3,915
-867
| -18% | -$674K | 0.81% | 21 |
|
|
2023
Q4 | $2.79M | Sell |
4,782
-459
| -9% | -$268K | 0.83% | 19 |
|
|
2023
Q3 | $2.82M | Sell |
5,241
-1,252
| -19% | -$672K | 1.17% | 11 |
|
|
2023
Q2 | $3.05M | Buy |
6,493
+896
| +16% | +$420K | 1.19% | 12 |
|
|
2023
Q1 | $1.92M | Buy |
5,597
+543
| +11% | +$186K | 0.8% | 20 |
|
|
2022
Q4 | $1.85M | Sell |
5,054
-621
| -11% | -$227K | 0.8% | 19 |
|
|
2022
Q3 | $1.84M | Buy |
5,675
+801
| +16% | +$259K | 0.88% | 20 |
|
|
2022
Q2 | $1.58M | Sell |
4,874
-153
| -3% | -$49.6K | 0.76% | 21 |
|
|
2022
Q1 | $1.44M | Buy |
5,027
+596
| +13% | +$171K | 0.59% | 26 |
|
|
2021
Q4 | $1.22M | Buy |
4,431
+564
| +15% | +$156K | 1.54% | 16 |
|
|
2021
Q3 | $893K | Sell |
3,867
-148
| -4% | -$34.2K | 1.36% | 19 |
|
|
2021
Q2 | $922K | Buy |
4,015
+1,745
| +77% | +$401K | 1.64% | 18 |
|
|
2021
Q1 | $424K | Buy |
+2,270
| New | +$424K | 1.3% | 28 |
|